Toronto Dominion Bank Sells 1,729 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Toronto Dominion Bank cut its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 8.0% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 20,014 shares of the exchange traded fund’s stock after selling 1,729 shares during the period. Toronto Dominion Bank’s holdings in SPDR S&P Biotech ETF were worth $1,977,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Healthcare of Ontario Pension Plan Trust Fund grew its holdings in shares of SPDR S&P Biotech ETF by 198.6% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock worth $911,825,000 after purchasing an additional 6,138,000 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd bought a new stake in SPDR S&P Biotech ETF in the 3rd quarter valued at $141,284,000. Affinity Asset Advisors LLC raised its stake in shares of SPDR S&P Biotech ETF by 105.4% in the 2nd quarter. Affinity Asset Advisors LLC now owns 37,550 shares of the exchange traded fund’s stock valued at $3,481,000 after buying an additional 737,550 shares in the last quarter. Mirae Asset Securities USA Inc. bought a new position in shares of SPDR S&P Biotech ETF during the 2nd quarter worth about $55,626,000. Finally, Assetmark Inc. boosted its position in shares of SPDR S&P Biotech ETF by 72,653.0% during the 3rd quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock valued at $58,223,000 after acquiring an additional 588,489 shares in the last quarter.

SPDR S&P Biotech ETF Stock Down 0.8 %

NYSEARCA:XBI opened at $93.40 on Monday. The firm has a market capitalization of $7.12 billion, a PE ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 12-month low of $81.14 and a 12-month high of $105.47. The firm has a 50-day moving average price of $98.05 and a 200 day moving average price of $97.13.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.